Cite
Scheipl S, Barnard M, Lohberger B, et al. Drug combination screening as a translational approach toward an improved drug therapy for chordoma. Cell Oncol (Dordr). 2021;44(6):1231-1242doi: 10.1007/s13402-021-00632-x.
Scheipl, S., Barnard, M., Lohberger, B., Zettl, R., Brcic, I., Liegl-Atzwanger, B., Rinner, B., Meindl, C., & Fröhlich, E. (2021). Drug combination screening as a translational approach toward an improved drug therapy for chordoma. Cellular oncology (Dordrecht), 44(6), 1231-1242. https://doi.org/10.1007/s13402-021-00632-x
Scheipl, Susanne, et al. "Drug combination screening as a translational approach toward an improved drug therapy for chordoma." Cellular oncology (Dordrecht) vol. 44,6 (2021): 1231-1242. doi: https://doi.org/10.1007/s13402-021-00632-x
Scheipl S, Barnard M, Lohberger B, Zettl R, Brcic I, Liegl-Atzwanger B, Rinner B, Meindl C, Fröhlich E. Drug combination screening as a translational approach toward an improved drug therapy for chordoma. Cell Oncol (Dordr). 2021 Dec;44(6):1231-1242. doi: 10.1007/s13402-021-00632-x. Epub 2021 Sep 22. PMID: 34550531; PMCID: PMC8648636.
Copy
Download .nbib